ArticleBioorganic & medicinal chemistry2007

A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.

Jenna L Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.